The Oncology Institute, McKesson expand strategic agreement for drug distribution
metamorworks/iStock via Getty Images Cancer-care provider The Oncology Institute (NASDAQ:TOI) on Monday said it had signed an expanded partnership ...
metamorworks/iStock via Getty Images Cancer-care provider The Oncology Institute (NASDAQ:TOI) on Monday said it had signed an expanded partnership with U.S.-drug distributor McKesson (NYSE:MCK) for drug distribution and clinical technology. The agreement is for multiple years and is expected to help streamline TOI's pharmaceutical distribution logistics. Cerritos, Calif.-based TOI was founded in 2007 and provides cancer-care through treatment centers, in-house dispensaries, and outpatient stem cell transplants and blood transfusions.